Status:
COMPLETED
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.
Lead Sponsor:
Montefiore Medical Center
Conditions:
Renal Transplant Osteodystrophy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Patients with kidney failure have underlying bone disease at the time of transplant. Fractures of various bones can be as high as 22%. Medication required for the transplant plays a role in bone loss....
Detailed Description
Participants who receive a living donor kidney transplant undergo a bone biopsy at the time of kidney transplant and after one year of protocol. Once adequate kidney function is established, both grou...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adults with end stage renal disease who are undergoing living donor kidney transplantation
Exclusion
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00266708
Start Date
October 1 2002
End Date
July 1 2008
Last Update
March 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467